Mergers News
Wednesday, January 25, 2017
J&J to buy Actelion for $30 billion
ZURICH, Jan 26 (Reuters) - Swiss biotech company Actelion
said on Thursday it had agreed to be purchased by
Johnson & Johnson in a $30 billion deal.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment